Drug intelligence / Profile preview

Improved ATT tablet

Development stage
Preclinical
Lead developer
Pharmesis International
Modality
Small Molecules
Administration
Oral
01

Overview

Improved ATT tablet (also known as Improved Anethol Trithione tablet or 改良茴三硫片) is an oral tablet formulation of anethole trithione (ATT) with enhanced bioavailability, developed by Pharmesis International. Anethole trithione is a synthetic organosulfur dithiolethione compound that acts as a sialogogue and choleretic agent. It is traditionally used to treat dry mouth (xerostomia) and hepatobiliary disorders such as cholecystitis, cholelithiasis, and dyspepsia, as well as an adjuvant therapy for acute and chronic hepatitis. The improved formulation is designed to enhance the bioavailability of anethole trithione, allowing for faster absorption and improved therapeutic efficacy. Pharmesis International's R&D pipeline includes plans for this improved tablet formulation alongside other ATT-based products.

Other names
Improved Anethol Trithione tablet改良茴三硫片
02

Targets

ADRA1A (α1A)CXADR (Coxsackievirus and adenovirus receptor)NQO1PXR (Pregnane X receptor)

Beyond the preview

Go deeper on Improved ATT tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Improved ATT tablet.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call